Moderna, Inc. (MRNA)

Moderna Revenue

Moderna had revenue of $145.00M in the quarter ending June 30, 2026, with 2.11% growth. This brings the company's total for the last twelve months to $2.23B, down -27.62% year-over-year. In the year 2025, Moderna had annual revenue of $1.94B, down -39.93%. That makes Moderna the 4,653rd largest company in the world by revenue and 1,233rd in the United States.

• Revenue (ttm): $2.23B
• Revenue Growth: -27.62%
• P/S Ratio: 46.30
• Revenue / Employee: $474,043
• Employees: 4,700
• Market Cap: 103.15B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Product Sales 1.82B 93.5%
• Stand-Ready Manufacturing 80.00M 4.1%
• Grant 22.00M 1.1%
• Collaboration 13.00M 0.7%
• Licensing and Royalty 11.00M 0.6%

By Geography

• United States 1.20B 61.7%
• Rest of World 692.00M 35.6%
• Europe 53.00M 2.7%

Fiscal year ended Dec 31, 2025 See the full Moderna breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.94B	-1.29B	-39.93%
Dec 31, 2024	3.24B	-3.61B	-52.75%
Dec 31, 2023	6.85B	-12.42B	-64.45%
Dec 31, 2022	19.26B	792.00M	4.29%
Dec 31, 2021	18.47B	17.67B	2,200.25%
Dec 31, 2020	803.00M	743.00M	1,238.33%
Dec 31, 2019	60.00M	-75.07M	-55.58%
Dec 31, 2018	135.07M	-70.76M	-34.38%
Dec 31, 2017	205.83M	97.43M	89.88%
Dec 31, 2016	108.40M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jul 31, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error